Joanna Miłoszewska

Joanna Miłoszewska

Auto-generated profile, based on publicly available information

Joanna Miłoszewska

Department of Cancer Biology, The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Roentgena 5, Warszawa, 02-781, POLAND

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2005 in Cell Proliferation
Verified
Journal Article
Closed access
MGM. Gos
M. Gos
JMJ. Miloszewska
J. Miloszewska
PSP. Swoboda
P. Swoboda
HTH. Trembacz
H. Trembacz
JSJ. Skierski
J. Skierski
PJP. Janik
P. Janik

1 January 2009
Verified
Journal Article
Closed access
MGMonika Gos
Monika Gos
JMJoanna Miłoszewska
Joanna Miłoszewska
MPMałgorzata Przybyszewska
Małgorzata Przybyszewska

29 February 2024 in Biofabrication
Verified
Journal Article
Open access
AKAgata Kurzyk
Agata Kurzyk
ASAnna Szumera-Cieckiewicz
Anna Szumera-Cieckiewicz
JMJoanna Miłoszewska
Joanna Miłoszewska
MCMagdalena Chechlinska
Magdalena Chechlinska
The current cancer research and drug testing are primarily based on 2D cell cultures and animal models. However, these methods have limitations and yield distinct drug response patterns. This study addressed this gap by developing an innovative in vitro human three-dimensional (3D) normal skin model and a multicellular model of human cutaneous squamous cell carcinoma (cSCC) using 3D bioprinting technology. Comparative analyzes were performed between bioprinted 3D-cSCC model, consisting of HaCaT keratinocytes, primary normal human dermal fibroblasts and A431 cancer cells (tricellular), bioprinted 3D-A431 model composed of A431 cancer cells only (monocellular), A431 cancer cell spheroids, and conventional 2D models. The models were structurally characterized by light microscopy, immunofluorescence (LIVE/DEAD assay, confocal microscopy) and immunohistochemistry (hematoxylin/eosin, p63, vimentin, Ki67, epidermal growth factor receptor stainings). The spatial arrangement of the 3D models was analyzed using the ARIVIS scientific image analysis platform. All models were also functionally assessed by cetuximab (CTX) response testing with the MTS assay. 3D-cSCC models were maintained for up to 16 weeks. Morphological and histological examinations confirmed the presence of skin-like layers in the bioprinted 3D models of normal skin, and the intricate and diverse features of the bioprinted skin cancer model, replicating the critical in vivo characteristics. In both mono- and tricellular bioprinted tumor constructs, there was a gradual formation and continuous growth of spheroid-like clusters of cancer cells, significantly influencing the morphology of the models. Cancer cells in the 3D bioprinted constructs showed reduced sensitivity to CTX compared to spheroids and 2D cultures. This study underscores the potential of 3D multicellular models in elucidating drug responses and gaining a better understanding the intricate interplay of cellular components within the tumor microenvironment. Developing the multicellular 3D tumor model paves the way for new research critical to advancing fundamental cancer research and future clinical applications, particularly drug response testing.

3 June 2011 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Closed access
PDF file
MPMałgorzata Przybyszewska
Małgorzata Przybyszewska
JMJoanna Miłoszewska
Joanna Miłoszewska
SRSylwia Rzońca
Sylwia Rzońca
HTHalina Trembacz
Halina Trembacz
KPKazimiera Pyśniak
Kazimiera Pyśniak
MMMaciej Malecki
Maciej Malecki
Post-radiation inflammatory reaction leads to an irreversible pulmonary fibrosis which may cause lethal respiratory insufficiency. Pathological inflammatory and fibrotic changes might be attenuated by inhibiting tumour necrosis factor (TNF)-α activity using TNF-α soluble receptors. Thus, an experimental antifibrotic gene therapy with the plasmid vector encoding a mouse soluble receptor I for TNF-α (psTNFR-I) was assessed. Soluble TNFR-I encoding gene was cloned into pcDNA3.1 plasmid. The ability of psTNFR-I expressing vector to transfect cells, and its biological activity in vitro and in vivo were examined by PCR, RT-PCR, MTT assay and ELISA. The C57Bl/6J mice received single intramuscular injection of psTNFR-I, conjugated with polyetylenimine (PEI) 25 kDa, equally divided to both hind legs, 3 days before irradiation (20 Gy, Co60), and either a single injection or ten injections once a week after irradiation. The data proved the effectiveness of psTNFR-I product to neutralise TNF-α activity in vitro. The in vivo plasmid incorporation and maintenance was confirmed. Measurements of plasma soluble TNFR-I levels showed that the in vivo gene transfer was effective. PEI was found to enhance transfection efficiency in vivo. The psTNFR-I/PEI complexes caused no toxicity in the transfected mice. C57Bl/6J mice that received prolonged psTNFR-I/PEI injections developed lethal fibrotic syndrome and died 8 weeks later than the mice treated with a double plasmid injection and the control mice treated with a control plasmid. Sequential administration of soluble TNFR-I by a nonviral, intramuscular gene transduction in the early and late post-radiation inflammatory phase prolonged survival of irradiated mice and attenuated the symptoms of lung fibrosis. The psTNFR-I gene transduction may provide a safe and simple method to partially neutralise TNF-α activity and prevent radiation-induced lung injury.

6 October 1986 in FEBS Letters
Verified
Journal Article
Closed access
PDF file
JMJoanna Miłoszewska
Joanna Miłoszewska
WTWitold Trawicki
Witold Trawicki
PJPrzemysław Janik
Przemysław Janik
JMJerzy Moraczewsk
Jerzy Moraczewsk
MPMałgorzata Przybyszewska
Małgorzata Przybyszewska
BSBożena Szaniawska
Bożena Szaniawska

1 January 2005 in Biochemical Pharmacology
Verified
Journal Article
Closed access
PDPatrycja M. Dubielecka
Patrycja M. Dubielecka
BJBożena Jaźwiec
Bożena Jaźwiec
SPStanisław Potoczek
Stanisław Potoczek
TWTomasz Wrobel
Tomasz Wrobel
JMJoanna Miłoszewska
Joanna Miłoszewska
ASAleksander F. Sikorski
Aleksander F. Sikorski